Delivery Order SPE2DB20D2001-SPE2DB25FPMCB
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,134.56, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 6, 2024. The contract has no set-aside designation, indicating it was an open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,224.68, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This is a Firm Fixed Price Delivery Order contract with a completion date of July 26, 2024. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,436.46, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication and has a completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific type of business. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The $27,908.97 firm fixed-price contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The $32,883.73 firm fixed-price contract has an ultimate completion date of July 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,879.98, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 31, 2025. The award is not designated under any set-aside program. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL. The $7,443.65 firm fixed-price delivery order contract has a completion date of February 13, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has a ceiling value of $2,917.81 and a completion date of December 16, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a $2,337.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the DLA, which is responsible for the Medical Supply Chain. The contract has an ultimate completion date of May 30, 2024. While the original solicitation was not provided, this delivery order appears to be part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,563.83, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This is a firm fixed-price delivery order contract with a completion date of February 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a significant $999,999,999 Indefinite...